(Q74645207)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Guillem Prats

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Carlos Guarner

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Ortiz J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Vila MC

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Soriano G

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Miñana J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Gana J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Mirelis B

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Novella MT

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sábat M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Andreu M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Solá R

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1064-1069

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

A prospective study of bacterial infections in patients with cirrhosis

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Bacterial infections in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Spontaneous bacterial peritonitis in cirrhosis. Incidence, diagnosis, and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Problems of bacterial infection in patients with liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Bacterial translocation in acute and chronic portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Clinical use of selective decontamination: the concept.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Selective intestinal decontamination prevents spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Hospital-acquired bacterial infections in patients with cirrhosis undergoing selective intestinal decontamination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Increased resistance to quinolone in Catalonia, Spain.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Spontaneous bacterial peritonitis and empyema by Escherichia coli resistant to norfloxacine in a patient on selective intestinal decontamination with norfloxacine.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Emergence of resistance during selective decontamination of the digestive tract

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Bacterial resistance to fluoroquinolones: lessons to be learned

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Quinolone resistance from a transferable plasmid.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510290406

7 January 2021

Identifiers

DOI

10.1002/HEP.510290406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094947%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference